AVROBIO Price Prediction
| AVRODelisted Stock | USD 1.40 0.04 2.78% |
Oversold Vs Overbought
61
Oversold | Overbought |
Using AVROBIO hype-based prediction, you can estimate the value of AVROBIO from the perspective of AVROBIO response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AVROBIO to buy its stock at a price that has no basis in reality. In that case, they are not buying AVROBIO because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AVROBIO after-hype prediction price | USD 1.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AVROBIO |
AVROBIO After-Hype Price Prediction Density Analysis
As far as predicting the price of AVROBIO at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AVROBIO or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AVROBIO, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AVROBIO Estimiated After-Hype Price Volatility
In the context of predicting AVROBIO's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AVROBIO's historical news coverage. AVROBIO's after-hype downside and upside margins for the prediction period are 1.40 and 1.40, respectively. We have considered AVROBIO's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AVROBIO is very steady at this time. Analysis and calculation of next after-hype price of AVROBIO is based on 3 months time horizon.
AVROBIO Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as AVROBIO is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AVROBIO backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AVROBIO, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.40 | 1.40 | 0.00 |
|
AVROBIO Hype Timeline
AVROBIO is presently traded for 1.40. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. AVROBIO is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on AVROBIO is about 0.0%, with the expected price after the next announcement by competition of 1.40. About 69.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.6. Some equities with similar Price to Book (P/B) outperform the market in the long run. AVROBIO had not issued any dividends in recent years. The entity had 1:12 split on the 21st of June 2024. Given the investment horizon of 90 days the next projected press release will be in about 5 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.AVROBIO Related Hype Analysis
Having access to credible news sources related to AVROBIO's direct competition is more important than ever and may enhance your ability to predict AVROBIO's future price movements. Getting to know how AVROBIO's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AVROBIO may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CWBR | CohBar Inc | 0.07 | 3 per month | 5.34 | 0.08 | 5.73 | (5.59) | 250.97 | |
| OCEA | Ocean Biomedical | 0.02 | 3 per month | 0.00 | (0.08) | 7.46 | (6.06) | 28.33 | |
| ENVB | Enveric Biosciences | 0.08 | 6 per month | 0.00 | (0.15) | 6.25 | (7.50) | 28.33 | |
| ELEV | Elevation Oncology | (0.02) | 9 per month | 0.00 | (0.08) | 5.77 | (8.22) | 22.21 | |
| ZURA | Zura Bio Limited | (0.21) | 9 per month | 0.00 | (0.11) | 7.95 | (7.94) | 26.70 | |
| HEPA | Hepion Pharmaceuticals | (0.02) | 4 per month | 0.00 | (0.06) | 8.06 | (8.11) | 33.54 | |
| EFTR | Effector Therapeutics | (0.06) | 4 per month | 0.00 | (0.31) | 8.70 | (27.78) | 88.91 |
AVROBIO Additional Predictive Modules
Most predictive techniques to examine AVROBIO price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AVROBIO using various technical indicators. When you analyze AVROBIO charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AVROBIO Predictive Indicators
The successful prediction of AVROBIO stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AVROBIO, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AVROBIO based on analysis of AVROBIO hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AVROBIO's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AVROBIO's related companies.
Story Coverage note for AVROBIO
The number of cover stories for AVROBIO depends on current market conditions and AVROBIO's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AVROBIO is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AVROBIO's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AVROBIO Short Properties
AVROBIO's future price predictability will typically decrease when AVROBIO's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AVROBIO often depends not only on the future outlook of the potential AVROBIO's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AVROBIO's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.6 M | |
| Cash And Short Term Investments | 98.3 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in AVROBIO Stock
If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |